Not applicableEnded earlyNCT02276651What this trial is testingObservational Trial of a Therapeutic Platelet Transfusion RegimenWho this might be right forAcute Myeloid LeukemiaThrombocytopenia Klinikum Nürnberg 25
Testing effectiveness (Phase 2)Looking for participantsNCT04047641What this trial is testingCladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeWho this might be right forAcute Myeloid LeukemiaBlasts 20 Percent or More of Bone Marrow Nucleated CellsHigh Risk Myelodysplastic Syndrome+5 more M.D. Anderson Cancer Center 80
Not applicableLooking for participantsNCT07511829What this trial is testingWearAble Technology for Collecting Health Data in People Who Are the Transfused (WATCH Transfused) - A UK Exploratory Study to Improve Quality of Life and the Efficacy of Transfusion Supportive Care in People With Blood Cancers Undergoing TreatmentWho this might be right forMDS (Myelodysplastic Syndrome)AML (Acute Myeloid Leukemia) University of Oxford 80
Early research (Phase 1)Looking for participantsNCT06378437What this trial is testingGLB-001 in Patients With Myeloid MalignanciesWho this might be right forPolycythemia VeraEssential ThrombocythemiaMyelofibrosis+3 more Hangzhou GluBio Pharmaceutical Co., Ltd. 108
Not applicableWithdrawnNCT03138395What this trial is testingICare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AMLWho this might be right forAcute LeukemiaMyelodysplastic SyndromesAML+1 more University of Florida
Testing effectiveness (Phase 2)Study completedNCT00448357What this trial is testingAllogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based RegimenWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more UNC Lineberger Comprehensive Cancer Center 54
Early research (Phase 1)WithdrawnNCT04896112What this trial is testingLNK01002 in Patients With Primary or Secondary Myelofibrosis,Polycythemia Vera or Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaPrimary MyelofibrosisPost-polycythemia Vera Myelofibrosis+2 more Lynk Pharmaceuticals Co., Ltd
Testing effectiveness (Phase 2)Study completedNCT00854945What this trial is testingStudy of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AMLWho this might be right forMyelodysplastic SyndromeAcute Myeloid Leukemia Traws Pharma, Inc. 36
Early research (Phase 1)Study completedNCT03236857What this trial is testingThe Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory MalignanciesWho this might be right forMalignanciesAcute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)+2 more AbbVie 143
Testing effectiveness (Phase 2)Study completedNCT04267081What this trial is testingStudy of Venetoclax in Combination With Azacytidine in AML Patients Selected Using Ex Vivo Drug Sensitivity ScreeningWho this might be right forAcute Myeloid Leukemia Helsinki University Central Hospital 104
Early research (Phase 1)Study completedNCT02323607What this trial is testingPacritinib and Chemotherapy in Treating Patients With Acute Myeloid Leukemia and FLT3 MutationsWho this might be right forRecurrent Adult Acute Myeloid LeukemiaSecondary Acute Myeloid LeukemiaTherapy-Related Acute Myeloid Leukemia+1 more Bhavana Bhatnagar 13
Early research (Phase 1)Looking for participantsNCT07439211What this trial is testingAssessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia, MyeloidLeukemiaAcute Myeloid Leukemia+1 more Jacqueline Garcia, MD 48
Not applicableLooking for participantsNCT06111612What this trial is testingIntensive Conditioning withTHI/Bu/Flu/Ara-C in Allo-HSCT for Myeloid Malignancies With Extramedullary InvolvementWho this might be right forAcute Myeloid LeukemiaMyelodysplastic NeoplasmChronic Myelomonocytic Leukemia+2 more Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Early research (Phase 1)WithdrawnNCT06007911What this trial is testingVenetoclax-Navitoclax With Cladribine-based Salvage Therapy in Patients With Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forRelapsed Adult AMLRefractory AML Medical College of Wisconsin
Early research (Phase 1)Study completedNCT00101179What this trial is testingMS-275 and Azacitidine in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaChronic Myelomonocytic Leukemiade Novo Myelodysplastic Syndrome+5 more National Cancer Institute (NCI) 63
Not applicableNot Yet RecruitingNCT07717164What this trial is testingPRAISE-IR Versus CIBMTR ControlsWho this might be right forALL (Acute B-Lymphoblastic Leukemia)AML (Acute Myeloid Leukemia)MDS (Myelodysplastic Syndrome) Miltenyi Biomedicine GmbH 51
Testing effectiveness (Phase 2)Ended earlyNCT02991898What this trial is testingAdoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme MalignanciesWho this might be right forAcute Lymphoblastic LeukemiaBurkitt LymphomaNatural Killer Cell Malignancies+15 more Masonic Cancer Center, University of Minnesota 3
Large-scale testing (Phase 3)Study completedNCT03250338What this trial is testingStudy Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AMLWho this might be right forRelapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations Arog Pharmaceuticals, Inc. 106
Not applicableStudy completedNCT02410252What this trial is testingUse Feasibility of the iThermonitor in Pediatrics Patients on Myelosuppresive TherapiesWho this might be right forAcute Lymphocytic LeukemiaAcute Myeloid LeukemiaNon-Hodgkin Lymphoma Massachusetts General Hospital 25
Testing effectiveness (Phase 2)Study completedNCT01736943What this trial is testingBortezomib and Doxil for the Treatment of Patients With Acute Myelogenous LeukemiaWho this might be right forAcute Myelogenous Leukemia Joseph Tuscano 25